NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine
India’s pharmaceutical pricing regulator has allowed a one-time price hike of 50 per cent for three key drugs
Read moreIndia’s pharmaceutical pricing regulator has allowed a one-time price hike of 50 per cent for three key drugs
Read moreDrug firm Unichem Laboratories on Thursday said it has received approval from the US health regulator to
Read morePutting all controversies to rest, the World Health Organization (WHO) on Friday said that it never certified any
Read moreNatco Pharma aims to launch around 10 new products every year in the Indian market, the city-based
Read moreIt has been more than six months since the first Covid-19 infection was reported. Now, even as
Read more